Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice
Open Access
- 2 December 2020
- journal article
- research article
- Published by Springer Nature in Endocrine Pathology
- Vol. 32 (1) , 17-34
Abstract
The majority of parathyroid disease encountered in routine practice is due to single parathyroid adenoma, of which the majority arise as sporadic tumors. This is usually a straightforward diagnosis in endocrine pathology when in the appropriate clinical setting, although subsets of cases will exhibit atypical histological features that may warrant additional immunohistochemical and genetic analyses to estimate the malignant potential. Parathyroid carcinomas on the other hand, are bona fide malignant tumors characterized by their unequivocal invasion demonstrated through routine histology or metastasis. The ultimate endpoint for any molecular marker discovered through laboratory investigations is to be introduced in clinical routine practice and guide the surgical pathologist in terms of diagnostics and prognostication. For parathyroid tumors, the two main diagnostic challenges include the distinction between parathyroid adenoma and parathyroid carcinoma, as well as the pinpointing of hereditable disease for familial screening purposes. While numerous markers on genetic, epigenetic, and protein levels have been proposed as discriminative in these aspects, this review aims to condense the scientific coverage of these enigmatic topics and to propose a focused surgical pathology approach to the subject.Keywords
Funding Information
- Cancerfonden (Junior Clinical Investigator Award)
- Karolinska Institute
This publication has 161 references indexed in Scilit:
- Identification of Somatic Mutations in Parathyroid Tumors Using Whole-Exome SequencingThe Journal of Clinical Endocrinology & Metabolism, 2012
- The DNA methylome of benign and malignant parathyroid tumorsGenes, Chromosomes and Cancer, 2011
- Somatic Mutation and Germline Sequence Abnormalities inCDKN1B, Encoding p27Kip1, in Sporadic Parathyroid AdenomasThe Journal of Clinical Endocrinology & Metabolism, 2011
- Aberrant WNT/β-catenin signaling in parathyroid carcinomaMolecular Cancer, 2010
- Rare Germline Mutations in Cyclin-Dependent Kinase Inhibitor Genes in Multiple Endocrine Neoplasia Type 1 and Related StatesThe Journal of Clinical Endocrinology & Metabolism, 2009
- The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogeneProceedings of the National Academy of Sciences, 2008
- Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patientsMolecular Cancer, 2008
- An LRP5 Receptor with Internal Deletion in Hyperparathyroid Tumors with Implications for Deregulated WNT/β-Catenin SignalingPLOS Medicine, 2007
- Germ-line mutations in p27
Kip1
cause a multiple endocrine neoplasia syndrome in rats and humansProceedings of the National Academy of Sciences, 2006
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971